Mammoth Biosciences is a biotechnology company that develops clustered regularly interspaced short palindromic repeats (CRISPR) based platform for disease detection. It offers a DETECTR platform for the presence of specific nucleic acids in an indicative of disease, and actionable clinical information. The company also provides nuclease applications and new modalities that include gene writing, and epigenetic editing.